Riociguat: all 48 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Switching of Sildenafil to Riociguat in CTEPH PatientsRecruitingNCT06715280Phase 4
- Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKERecruitingNCT05762146Phase 2
- Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAHTerminatedNCT05339087Phase 2Results posted
- Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPHTerminatedNCT04954742Phase 4Results posted
- Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study)TerminatedNCT03273257Phase 2Results posted
- Riociguat in Scleroderma Associated Digital UlcersCompletedNCT02915835Phase 2Results posted
- Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapyCompletedNCT02891850Phase 4Results posted
- A Multi-Center Study of Riociguat in Patients With Sickle Cell DiseasesCompletedNCT02633397Phase 2Results posted
- Riociguat in Children With Pulmonary Arterial Hypertension (PAH)Active, not recruitingNCT02562235Phase 3Results posted
- Efficacy and Safety of Riociguat in Patients With Systemic SclerosisCompletedNCT02283762Phase 2Results posted
- Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION)CompletedNCT02191137Phase 4Results posted
- Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis PatientsTerminatedNCT02170025Phase 2Results posted
- Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)TerminatedNCT02138825Phase 2Results posted
- Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High AltitudeCompletedNCT02024386Phase 4Results posted
- Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters.CompletedNCT01179334Phase 2Results posted
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic DysfunctionTerminatedNCT01065454Phase 2Results posted
- Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation KineticsTerminatedNCT01065051Phase 2Results posted
- BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary HypertensionCompletedNCT00910429Phase 3Results posted
- BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial HypertensionCompletedNCT00863681Phase 3Results posted
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.CompletedNCT00855465Phase 3Results posted
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT00810693Phase 3Results posted
- Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.CompletedNCT00640315Phase 1Results posted
- Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated TabletsCompletedNCT06180096Phase 1
- Pulmonary Hypertension: Intensification and Personalisation of Combination RxActive, not recruitingNCT05825417Phase 4
- Effect of Riocigaut on Migraine Attack Induction in People With MigraineCompletedNCT05750446Not applicable
- Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPHTerminatedNCT05140525Phase 3
- Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy VolunteersCompletedNCT04776499Phase 1
- THERAPY-HYBRID-BPA TrialStatus unknownNCT04600492Phase 2
- Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Impaired Liver Function and Healthy Participants Matched for Age-, Gender-, and WeightCompletedNCT04366622Phase 1
- Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and WeightCompletedNCT04364464Phase 1
- A 2-part Study to Investigate the Effect of Macitentan in Healthy Male ParticipantsCompletedNCT04211272Phase 1
- Upfront Combination Pulmonary Arterial Hypertension TherapyStatus unknownNCT03809156Phase 4
- Treatment of Exercise-Induced Pulmonary Vascular Dysfunction After Pulmonary Thromboendarterectomy or Balloon Pulmonary AngioplastyCompletedNCT03409588Phase 2
- Clinical Study to Investigate Effect of Macitentan on Riociguat PharmacokineticsCompletedNCT03389321Phase 1
- Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary HypertensionCompletedNCT03074539Not applicable
- A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.CompletedNCT02759419Phase 4
- Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection FractionCompletedNCT02744339Phase 2
- Riociguat for Sarcoidosis Associated Pulmonary HypertensionStatus unknownNCT02625558Phase 4
- Interaction With HIV Antiretroviral AgentsCompletedNCT02556268Phase 1
- Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal WomenCompletedNCT02159326Phase 1
- Relative Bioavailability StudyCompletedNCT02159313Phase 1
- Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 InhibitorCompletedNCT02007629Phase 3
- Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) StimulatorCompletedNCT01926847Phase 2
- Relative Bioavailability and Food Effect StudyCompletedNCT01489488Phase 1
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic DysfunctionTerminatedNCT01172756Phase 2
- Coronary Vasomotor Response After Riociguat ExposureWithdrawnNCT01165931Phase 2
- Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TIDCompletedNCT00680654Phase 1
- An Open Multiple Dose Titration Study In Patients With Pulmonary HypertensionCompletedNCT00454558Phase 2